Results 331 to 340 of about 320,201 (374)

Does Adjuvant Metformin Reduce Olanzapine-Induced Metabolic Adverse Effects in Patients Diagnosed With Schizophrenia. [PDF]

Neuropsychopharmacol Rep
Butt A, Sadiq S.
europepmc   +1 more source

Long‐acting insulin analogues and the risk of diabetic nephropathy among patients with type 2 diabetes: A population‐based cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The risk of diabetic nephropathy among patients with type 2 diabetes (T2D) can be reduced through optimal glycaemic control. It is not known if the pharmacological properties of long‐acting insulin analogues may reduce the risk of diabetic complications compared with neutral protamine Hagedorn (NPH) insulin.
Julia Brillinger, Christopher Filliter, Shahrzad Salmasi, Estefania Zapata‐Bravo, Robert W. Platt, Oriana H. Y. Yu, Kristian B. Filion   +6 more
wiley   +1 more source

Impact of Metformin therapy on miR-9, miR-223, and miR-132 and inflammasome-related gen expression in obese and non-obes PCOS patients: A comparative study with healthy controls. [PDF]

PLoS One
Mirjalili SA, Kalantar SM, Montazeri F, Azizi R, Hosseini E, Zare F, Asgharzade S, Ashrafi Dehkordi K.   +7 more
europepmc   +1 more source

Beyond diabetes and obesity: GLP‐1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and neuroinflammation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Neurodegenerative diseases, including debilitating conditions like Alzheimer's and Parkinson's, are characterized by progressive neuronal loss, a process fundamentally driven by persistent chronic neuroinflammation and central metabolic dysfunction.
Renata Spezani, Carlos A. Mandarim‐de‐Lacerda   +1 more
wiley   +1 more source

Multiparameter MRI assessment of metformin and exercise effects on skeletal muscle in prediabetes: a randomized controlled trial. [PDF]

Eur Radiol Exp
Yu F, Dong Y, Ye N, Xing C, Lyu X, Chen Y, Yang X, Pan S.   +7 more
europepmc   +1 more source

ToF-SIMS Reveals Metformin-Driven Restoration of Hepatic Lipid and Amino Acid Profiles in a Type 2 Diabetes Rat Model. [PDF]

Int J Mol Sci
Skalska ME, Kaźmierczak M, Capcarova M, Kalafova A, Jaszcza K, Wojtysiak D.   +5 more
europepmc   +1 more source

The role of impaired adipogenesis in insulin resistance among non-obese individuals. [PDF]

Front Physiol
Almuraikhy S, Alser M, Naja K, Anwardeen N, Taha S, John J, Halim S, Badran S, Ahmed MB, Jarrar S, Aljassem G, Al-Mohannadi FS, Doi S, Abdel-Aziz A, Elaf YJ, Elrayess MA.   +15 more
europepmc   +1 more source

<i>In Vitro</i> Drug Release Kinetics and Antioxidant Activity of Metformin-Loaded Niosomes. [PDF]

ACS Omega
Çalışkan EE, Aydın YÇ, Ozbek EN, Alcın I, Kilinc E, Yetik Anacak G, Cetin Uyanikgil EO.   +6 more
europepmc   +1 more source

Therapeutic potential of metformin-based combination therapy in acute myeloid leukemia. [PDF]

Discov Oncol
Shamahmood MN, Miri A, Yousefi MJ, Mezginejad F.   +3 more
europepmc   +1 more source